AU3041671A - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
AU3041671A
AU3041671A AU30416/71A AU3041671A AU3041671A AU 3041671 A AU3041671 A AU 3041671A AU 30416/71 A AU30416/71 A AU 30416/71A AU 3041671 A AU3041671 A AU 3041671A AU 3041671 A AU3041671 A AU 3041671A
Authority
AU
Australia
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU30416/71A
Other languages
English (en)
Inventor
ALFRED RHEINER JR. and ROLF RICHIE WILLY BURKARD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU3041671A publication Critical patent/AU3041671A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU30416/71A 1970-07-24 1971-06-24 Pharmaceutical preparation Expired AU3041671A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1124070 1970-07-24
CHCH11240/70 1970-07-24

Publications (1)

Publication Number Publication Date
AU3041671A true AU3041671A (en) 1973-01-04

Family

ID=4371509

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30416/71A Expired AU3041671A (en) 1970-07-24 1971-06-24 Pharmaceutical preparation

Country Status (8)

Country Link
AU (1) AU3041671A (es)
BE (1) BE770403A (es)
DE (1) DE2137045A1 (es)
FR (1) FR2100948B1 (es)
GB (1) GB1330545A (es)
IL (1) IL37235A (es)
NL (1) NL7108189A (es)
ZA (1) ZA714076B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses

Also Published As

Publication number Publication date
FR2100948B1 (es) 1974-09-06
DE2137045A1 (de) 1972-01-27
IL37235A0 (en) 1971-10-20
ZA714076B (en) 1972-03-29
NL7108189A (es) 1972-01-26
FR2100948A1 (es) 1972-03-24
GB1330545A (en) 1973-09-19
BE770403A (fr) 1972-01-24
IL37235A (en) 1973-10-25

Similar Documents

Publication Publication Date Title
CA955252A (en) Pharmaceutical compositions
AU450603B2 (en) New pharmaceutical compositions
CA932661A (en) Pharmaceutical preparation
AU456174B2 (en) Pharmaceutical preparation
AU3628971A (en) New pharmaceutical preparations
AU3701671A (en) Pharmaceutical formulations
AU2682871A (en) Pharmaceutical compositions
CA969953A (en) Pharmaceutical compositions
AU3017971A (en) Pharmaceutical composition
AU452135B2 (en) Pharmaceutical compositions
CA940452A (en) Pharmaceutical tablet
AU3041671A (en) Pharmaceutical preparation
AU3252271A (en) Vaccine preparation
CA964589A (en) Oral preparation
CA918066A (en) Pharmaceutical preparations
CA855186A (en) Pharmaceutical preparation
AU464325B2 (en) New pharmaceutical preparations
ZA713227B (en) Pharmaceutical preparation
AU447332B2 (en) Pharmaceutical preparations
AU458023B2 (en) Pharmaceutical preparations
CA840975A (en) Pharmaceutical composition
CA1013254A (en) Pharmaceutical composition
CA840974A (en) Pharmaceutical composition
CA961486A (en) Pharmaceutical compounds
CA916058A (en) Anti-hemorrhoidal preparation